Aldeyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALDX and other ETFs, options, and stocks.About ALDX
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases.
CEOTodd C. Brady
CEOTodd C. Brady
Employees8
Employees8
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2004
Founded2004
Employees8
Employees8
ALDX Key Statistics
Market cap117.93M
Market cap117.93M
Price-Earnings ratio-4.31
Price-Earnings ratio-4.31
Dividend yield—
Dividend yield—
Average volume1.17M
Average volume1.17M
High today$1.99
High today$1.99
Low today$1.84
Low today$1.84
Open price$1.88
Open price$1.88
Volume2.15M
Volume2.15M
52 Week high$6.18
52 Week high$6.18
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
Aldeyra Therapeutics(ALDX) stock is priced at $1.96, giving the company a market capitalization of 117.93M. It carries a P/E multiple of -4.31.
On 2026-06-19, Aldeyra Therapeutics(ALDX) stock traded between a low of $1.84 and a high of $1.99. Shares are currently priced at $1.96, which is +6.5% above the low and -1.5% below the high.
Aldeyra Therapeutics(ALDX) shares are trading with a volume of 2.15M, against a daily average of 1.17M.
During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.07 at its lowest and $6.18 at its peak.
During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.07 at its lowest and $6.18 at its peak.
People also own
Based on the portfolios of people who own ALDX. This list is generated using Robinhood data, and it’s not a recommendation.